FDA Reconsiders Weight Loss Drug Qnexa
The FDA is once again considering approval of an experimental weight loss drug it rejected a year ago over concerns about potential heart problems and birth defects in babies born to women who take it.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.